Assuntos
Discite , Fístula , Lesão Pulmonar , Humanos , Discite/diagnóstico por imagem , Discite/etiologia , Vértebras Lombares , PulmãoAssuntos
Varicela , Dermatite , Herpes Zoster , Radiculopatia , Humanos , Idoso , Radiculopatia/etiologia , Herpes Zoster/complicações , Herpesvirus Humano 3 , VacinaçãoRESUMO
INTRODUCTION: The objective of this study is to evaluate the efficacy of a change in the management of the risk of delirium in an orthogeriatric unit. MATERIAL AND METHODS: Prospective, comparative, non-randomised study of two cohorts of patients. One cohort (control group) treated with standard therapy with tramadol rescue and diazepam and another cohort (experimental group) treated with rescue with morphine at low doses and short half-life benzodiazepines as well as preventive treatment with neuroleptics in patients at high risk. RESULTS: Eighty-five patients were included (42 in the control group and 43 in the experimental group). Mean age: 85 (71-105). Twenty-nine patients (34%) had an episode of delirium during the current admission, 16 patients (38%) in the control group and 13 patients (30%) in the experimental group respectively (P=.498). The mean duration of delirium in the 29 patients who presented it was 5.3 days. This duration in the control group was 6.6 days and in the experimental group 3.8 days (P=.031). In the group of patients who had previous delirium, a lower incidence of delirium was seen during the current admission in the experimental group (80% vs 17% P=.036). CONCLUSIONS: Experimental treatment has been effective since a trend to a lower incidence of delirium has been observed. In the patients who have suffered an episode of delirium, the treatment served to decrease its duration with statistically significant differences.
Assuntos
Delírio/prevenção & controle , Fraturas do Quadril/cirurgia , Complicações Pós-Operatórias/prevenção & controle , Idoso , Idoso de 80 Anos ou mais , Analgésicos Opioides/administração & dosagem , Antipsicóticos/uso terapêutico , Benzodiazepinas/uso terapêutico , Estudos de Casos e Controles , Delírio/tratamento farmacológico , Delírio/epidemiologia , Diazepam/uso terapêutico , Feminino , Humanos , Modelos Logísticos , Masculino , Morfina/administração & dosagem , Complicações Pós-Operatórias/tratamento farmacológico , Estudos Prospectivos , Fatores de Tempo , Tramadol/uso terapêuticoRESUMO
The purpose of this study is to determine whether there are some differences in the treatment responses to a multidisciplinary fibromyalgia (FM) treatment related with the baseline body mass index (BMI) of the participants. Inclusion criteria consisted of female sex, a diagnosis of FM (American College of Rheumatology criteria), age between 18 and 60 years, and between 3 and 8 years of schooling. Baseline BMI was determined, and patients were randomly assigned to one of the two treatment conditions: conventional pharmacologic treatment or multidisciplinary treatment. Outcome measures were pain intensity, functionality, catastrophizing, psychological distress, health-related quality of life, and sleep disturbances. One hundred thirty patients participated in the study. No statistical significant differences regarding pre-treatment outcomes were found among the different BMI subgroups, and between the two experimental conditions for each BMI category. General linear model analysis showed a significant interaction group treatment × time in pain intensity (p < .01), functionality (p < .0001), catastrophizing (p < .01), psychological distress (p < .0001), sleep index problems (p < .0001), and health-related quality of life (p < .05). No significant interactions were found in BMI × time, and in BMI × group treatment × time. There are not differences among normal weight, overweight and obese patients with FM regarding their response to a multidisciplinary treatment programme for FM which combines pharmacological treatment, education, physical therapy and cognitive behavioural therapy.
